Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $522.59 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $130.91 | 7 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $107.57 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $87.97 | 5 | $0 (2024) |
| Medtronic, Inc. | $71.52 | 2 | $0 (2023) |
| Lilly USA, LLC | $44.56 | 3 | $0 (2024) |
| Mylan Specialty L.P. | $19.60 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $17.52 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.28 | 1 | $0 (2020) |
| Boston Scientific Corporation | $15.11 | 1 | $0 (2024) |
| Currax Pharmaceuticals LLC | $12.55 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.11 | 6 | AstraZeneca Pharmaceuticals LP ($44.33) |
| 2023 | $231.60 | 11 | AbbVie Inc. ($81.37) |
| 2022 | $88.23 | 5 | ABBVIE INC. ($34.55) |
| 2021 | $28.70 | 2 | AbbVie Inc. ($14.99) |
| 2020 | $15.28 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($15.28) |
| 2019 | $49.67 | 3 | Mylan Specialty L.P. ($19.60) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: RESPIRATORY | ||||||
| 07/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: WATCHMAN_IC | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Respiratory | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Diabetes | ||||||
| 11/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/18/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Respiratory | ||||||
| 02/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Neuroscience | ||||||
| 01/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
| 01/23/2023 | Medtronic, Inc. | MINIMED 770G (Device) | Food and Beverage | In-kind items and services | $57.98 | General |
| Category: Durable Pump | ||||||
| 01/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2022 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 03/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: VACCINES | ||||||
| 03/10/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Respiratory | ||||||
| 01/31/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 183 | 273 | $16,188 | $5,101 |
| 2022 | 6 | 158 | 257 | $12,196 | $4,307 |
| 2021 | 2 | 52 | 66 | $1,122 | $327.54 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 42 | $8,022 | $2,583 | 32.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 22 | 24 | $2,580 | $1,048 | 40.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 50 | 97 | $3,163 | $907.52 | 28.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 19 | 21 | $1,095 | $340.20 | 31.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 51 | 75 | $702.00 | $165.00 | 23.5% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 13 | 14 | $626.00 | $58.08 | 9.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 28 | $5,348 | $1,448 | 27.1% |
| 86328 | Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | Office | 2022 | 21 | 25 | $1,250 | $1,119 | 89.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 44 | 91 | $2,821 | $869.36 | 30.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 19 | 29 | $1,421 | $473.48 | 33.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 12 | 15 | $735.00 | $244.46 | 33.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 43 | 69 | $621.00 | $153.60 | 24.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 20 | 24 | $744.00 | $233.04 | 31.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 32 | 42 | $378.00 | $94.50 | 25.0% |
About Dr. Daniel Bender, DO
Dr. Daniel Bender, DO is a Family Medicine healthcare provider based in Riverton, Wyoming. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2017. The National Provider Identifier (NPI) number assigned to this provider is 1427585488.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Bender, DO has received a total of $522.59 in payments from pharmaceutical and medical device companies, with $109.11 received in 2024. These payments were reported across 28 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($522.59).
As a Medicare-enrolled provider, Bender has provided services to 393 Medicare beneficiaries, totaling 596 services with total Medicare billing of $9,736. Data is available for 3 years (2021–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Riverton, WY
- Active Since 05/21/2017
- Last Updated 04/20/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1427585488
Products in Payments
- VRAYLAR (Drug) $130.91
- BREZTRI (Drug) $78.43
- MINIMED 770G (Device) $57.98
- TRELEGY ELLIPTA (Drug) $51.71
- FARXIGA (Drug) $29.14
- MOUNJARO (Drug) $28.62
- Yupelri (Drug) $19.60
- SHINGRIX (Biological) $19.07
- NEXPLANON (Drug) $17.52
- AREXVY (Drug) $17.19
- EMGALITY (Drug) $15.94
- XIFAXAN (Drug) $15.28
- WATCHMAN Access System (Device) $15.11
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $13.54
- CONTRAVE (Drug) $12.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Riverton
Stephen Devenport, Md, MD
Family Medicine — Payments: $9,295
Dr. Don Allred, Do, DO
Family Medicine — Payments: $4,878
Eric Ridgway, Md, MD
Family Medicine — Payments: $4,635
Dr. Daniel Thompson, Md, MD
Family Medicine — Payments: $3,862
Dr. Bruce Depew, Md, MD
Family Medicine — Payments: $3,302
Mr. Demar Hill, M.d, M.D
Family Medicine — Payments: $3,026